These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1873817)

  • 1. Infrequent p53 gene mutations in medulloblastomas.
    Saylors RL; Sidransky D; Friedman HS; Bigner SH; Bigner DD; Vogelstein B; Brodeur GM
    Cancer Res; 1991 Sep; 51(17):4721-3. PubMed ID: 1873817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
    Adesina AM; Nalbantoglu J; Cavenee WK
    Cancer Res; 1994 Nov; 54(21):5649-51. PubMed ID: 7923211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
    Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
    Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts.
    Philipova T; Baryawno N; Hartmann W; Pietsch T; Druid H; Johnsen JI; Ekström TJ
    Int J Oncol; 2011 Mar; 38(3):843-9. PubMed ID: 21184030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
    Pietsch T; Koch A; Wiestler OD
    Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity and p53 polymorphism Pro72Arg in a young patient with medulloblastoma.
    Sardi I; Giunti L; Donati P; Lacitignola L; Tucci F; Sardo L; Giovannucci Uzielli ML; Bernini G
    Oncol Rep; 2003; 10(3):773-5. PubMed ID: 12684657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
    Cote RJ; Jhanwar SC; Novick S; Pellicer A
    Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
    Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 expression in four human medulloblastoma-derived cell lines.
    Srinivasan J; Berger MS; Silber JR
    Childs Nerv Syst; 1996 Feb; 12(2):76-80. PubMed ID: 8674085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.
    Biegel JA; Burk CD; Barr FG; Emanuel BS
    Cancer Res; 1992 Jun; 52(12):3391-5. PubMed ID: 1596898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
    Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
    Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
    von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
    Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.